HMGB1 and B-cell chronic lymphocytic leukemia: Hence, we sought to investigate whether these functional properties, required for ICD transduction, could be associated with SpiD3 treatment, given that classical immunogenic DAMPs (CALR, ATP, and HMGB1) were emitted from CLL cells subjected to SpiD3 treatment.